mHealth Technologies for Heart Failure
(iCardia4HF Trial)
Trial Summary
What is the purpose of this trial?
The goal of this factorial randomized trial is to examine the independent and synergistic efficacies of two mobile health technology interventions in people with chronic heart failure. The first intervention involves the use of multiple consumer mHealth apps and sensor devices (MyApps) for heart failure self-care (maintenance, monitoring, and management). The second intervention is a program of tailored text messages (Text4HF) targeting modifiable behavioral factors associated with heart failure self-care non-adherence. The main questions this study aims to answer are: 1. Can the use of consumer mHealth apps and devices (MyApps) improve heart failure self-care and reduce days lost due to cardiovascular hospitalization or death for any cause? 2. Can a program of individually tailored text messages (Text4HF) improve heart failure self-care and reduce the days lost due to cardiovascular hospitalization or death for any cause? 3. Can MyApps and Text4HF combined lead to greater improvements in heart failure self-care and days lost due to cardiovascular hospitalization or death for any cause
Do I need to stop my current medications for this trial?
The trial does not specify if you need to stop your current medications. However, it mentions that participants must be actively treated with oral loop diuretics for chronic heart failure, so you may need to continue those.
What data supports the effectiveness of the treatment MyApps, MyApps, Consumer mHealth Apps and Devices, Text4HF, Text4HF, Tailored Text Messages for Heart Failure Self-Care?
Research suggests that mobile health apps can help people with heart failure manage their condition better by reducing hospital visits and improving their quality of life. These apps support self-care by helping patients stay engaged with their health management and communicate more effectively with healthcare providers.12345
Is the mHealth app for heart failure safe for humans?
How is the mHealth treatment for heart failure unique?
The mHealth treatment for heart failure, including MyApps and Text4HF, is unique because it uses mobile health apps to support self-care by providing tailored text messages and consumer-friendly apps designed with input from patients and caregivers, which helps patients manage their condition more effectively in their daily lives.12346
Research Team
Spyros Kitsiou, PhD
Principal Investigator
University of Illinois Chicago
Eligibility Criteria
This trial is for people with chronic heart failure. Participants should be willing to use mobile health apps and devices daily for self-care, and receive tailored text messages aimed at improving their adherence to self-care routines.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Induction
Participants receive the MyApps and/or Text4HF interventions to promote heart failure self-care adherence
Adoption
Continued use of MyApps and/or Text4HF interventions with reduced frequency of text messages
Follow-up
Participants are monitored for maintenance efficacy of interventions and health outcomes
Treatment Details
Interventions
- MyApps
- Text4HF
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Illinois at Chicago
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator